tradingkey.logo
tradingkey.logo
Pesquisar

Harvard Bioscience Inc

HBIO
Adicionar à lista de desejos
6.050USD
-0.100-1.63%
Fechamento 07/01, 16:00ETCotações atrasadas em 15 min
27.29MValor de mercado
PerdaP/L TTM

Mais detalhes de Harvard Bioscience Inc Empresa

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Informações de Harvard Bioscience Inc

Código da empresaHBIO
Nome da EmpresaHarvard Bioscience Inc
Data de listagemOct 21, 2013
CEODuke (John D)
Número de funcionários330
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 21
Endereço84 October Hill Rd
CidadeHOLLISTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01746-1371
Telefone15088938999
Sitehttps://www.harvardbioscience.com/
Código da empresaHBIO
Data de listagemOct 21, 2013
CEODuke (John D)

Executivos da empresa Harvard Bioscience Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
58.67K
+28.22%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
27.56K
+60.08%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
26.56K
+62.34%
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
58.67K
+28.22%
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
27.56K
+60.08%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
26.56K
+62.34%
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Harvard Bioscience Inc?

Os cinco principais acionistas de Harvard Bioscience Inc são: Ms. Katherine Anne Eade, J.D.

Quantas instituições possuem ações da Harvard Bioscience Inc (HBIO)?

Em 2026Q1, 201 instituições possuíam ações da Harvard Bioscience Inc, com valor de mercado aproximado de 2.44M, representando 54.17% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -447956.00.

Qual é a maior fonte de receita da Harvard Bioscience Inc?

Em 2026Q1, o segmento de negócios Instruments, equipment, software and accessories gerou a maior receita para Harvard Bioscience Inc, totalizando 78.26M e representando 90.42% da receita total.